Institut Pasteur Korea Finds COVID-19 Treatment Candidate 600 Times Stronger than Remdesivir
Institut Pasteur Korea announced on May 14 that nafamostat, an acute pancreatitis treatment and a blood anticoagulant component, has antiviral effects against the new coronavirus.Institut Pasteur Korea has been conducting drug recreation research since February to discover candidates for COVID-19 tr
Continue Reading
Additional Contributions:





















Join the Discussion